Serum values and urinary rates of several enzymes (lactic-acid dehydrogenase, leucine aminopeptidase, malic dehydrogenase, α-amylase) were investigated in groups of patients characterized by clinical and biochemical features, as well as in healthy volunteers before and after i.v. infusion of calcium gluconate (type Kyle). Urinary LDH excretion in patients with hypercalciuric symptoms (oxalate stones) were significantly increased and primary hyperparathyroidism was refractory to otherwise calcium-induced changes of α-amylase in serum, permitting differential diagnosis. Stones resulting from urinary-tract infection evoked elevated LAP values in serum; urinary malic dehydrogenase in all patients was higher, compared to volunteers. The results of this study suggest that stone formation in human kidney is accompanied by elementary metabolic changes, possibly not respected enough as to their validity in the as yet unknown etiology of this disorder.

Keywords:
Kidney stones, Lactic dehydrogenase, Leucine aminopeptidase, α-Amylase, Malic dehydrogenase, Serum values, Urinary rates
This content is only available via PDF.
© 1973 S. Karger AG, Basel
1973
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.